Zobrazeno 1 - 10
of 15
pro vyhledávání: '"María del Mar Fernández de Gatta"'
Publikováno v:
FarmaJournal. 4:31-40
La identificación de medicamentos de alto riesgo en pacientes crónicos (MARC) polimedicados como los ancianos constituye una estrategia útil para aumentar la seguridad de la farmacoterapia. Con ese fin en el trabajo se aplica el listado MARC en un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91fc1c1135a29868490340b15e2e9206
https://doi.org/10.14201/fj2019423140
https://doi.org/10.14201/fj2019423140
Autor:
Dolores Santos-Buelga, Jesús María Hernández-Rivas, Alejandro Martín, María del Mar Fernández de Gatta, María José García, Jonás Samuel Pérez-Blanco
Publikováno v:
British Journal of Clinical Pharmacology. 82:1517-1527
Aims The aims of the study were: (i) to characterize the pharmacokinetics (PK) of doxorubicin (DOX) and doxorubicinol (DOXol) in patients diagnosed with non-Hodgkin's lymphoma (NHL) using a population approach; (ii) to evaluate the influence of vario
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aec2ac893eeb165ebf958ad201433b9
https://doi.org/10.1111/bcp.13070
https://doi.org/10.1111/bcp.13070
Autor:
Jonás Samuel, Pérez-Blanco, Dolores, Santos-Buelga, María Del Mar, Fernández de Gatta, Jesús María, Hernández-Rivas, Alejandro, Martín, María José, García
Publikováno v:
British journal of clinical pharmacology. 82(6)
The aims of the study were: (i) to characterize the pharmacokinetics (PK) of doxorubicin (DOX) and doxorubicinol (DOXol) in patients diagnosed with non-Hodgkin's lymphoma (NHL) using a population approach; (ii) to evaluate the influence of various co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2708a26dc71922dff9bbf09e1cc138a
https://pubmed.ncbi.nlm.nih.gov/27447545
https://pubmed.ncbi.nlm.nih.gov/27447545
Autor:
Marta Paz Pérez, Félix Martín González, María del Mar Fernández de Gatta, Natalia Revilla, Ana Martín-Suárez
Publikováno v:
British Journal of Clinical Pharmacology. 70:201-212
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Despite the frequent use of vancomycin in intensive care unit (ICU) patients, few studies aimed at characterizing vancomycin population pharmacokinetics have been performed in this critical population. * Pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f48a8fccf15e89a531e3bc9c6b6408e
https://doi.org/10.1111/j.1365-2125.2010.03679.x
https://doi.org/10.1111/j.1365-2125.2010.03679.x
Autor:
María del Mar Fernández de Gatta, Alfonso Domínguez-Gil, Ana Cobo, Ana Martín-Suárez, M. V. Calvo
Publikováno v:
Therapeutic Drug Monitoring. 32:169-176
Analytical interferences in digoxin immunoassays constitute a well-known problem, with repercussions for therapeutic drug monitoring. Clinically effective doses of spironolactone and potassium canrenoate cross-react in several digoxin immunoassays, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25ba22ca175b63177cfacc4c08b9d880
https://doi.org/10.1097/ftd.0b013e3181cdc93e
https://doi.org/10.1097/ftd.0b013e3181cdc93e
Autor:
María José García Sánchez, Jesús María Hernández-Rivas, María Luisa Sayalero Marinero, Jonás Samuel Pérez-Blanco, Francisco González López, María del Mar Fernández de Gatta
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
A rapid and simple UHPLC-fluorescence detection method for the quantification of doxorubicin and its main metabolite, doxorubicinol, in human plasma has been developed. The method was also validated for its application in therapeutic drug monitoring,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4e0f9552e5ef46bc92e00dfb0c2636
http://hdl.handle.net/10261/134715
http://hdl.handle.net/10261/134715
Autor:
Rosa Sepúlveda Correa, Salvador Cabrera Figueroa, María José García Sánchez, Lorena Hernández García, Carmen Bustos Bernal, Alfonso Domínguez-Gil Hurlé, María del Mar Fernández de Gatta
Publikováno v:
Therapeutic drug monitoring. 32(5)
The aim of this study was to show the benefits of combining therapeutic drug monitoring (TDM) and pharmacogenetic analyses to optimize efavirenz (EFV) therapy. Patients were selected to minimize nongenetic differences between patients: 32 HIV adheren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4b2a768c3182c1596a56685ab32401
https://pubmed.ncbi.nlm.nih.gov/20720517
https://pubmed.ncbi.nlm.nih.gov/20720517
Autor:
Natalia, Revilla, Ana, Martín-Suárez, Marta Paz, Pérez, Félix Martín, González, María Del Mar, Fernández de Gatta
Publikováno v:
British journal of clinical pharmacology. 70(2)
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Despite the frequent use of vancomycin in intensive care unit (ICU) patients, few studies aimed at characterizing vancomycin population pharmacokinetics have been performed in this critical population. * Pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d2b18c235589e6da17582eb2134f7ad
https://pubmed.ncbi.nlm.nih.gov/20653673
https://pubmed.ncbi.nlm.nih.gov/20653673
Autor:
Josæ© M. Lanao, Silvia Romano Moreno, Alfonso Domínguez-Gil, Ramón Ardanuy, M. V. Calvo, María del Mar Fernández de Gatta
Publikováno v:
The Journal of pharmacy and pharmacology. 61(6)
Objectives The aim of this study was to evaluate the reliability for dosage individualization and Bayesian adaptive control of several literature-retrieved amikacin population pharmacokinetic models in patients who were critically ill. Methods Four p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2112d76ee468d15a112caafcb4c680c2
https://pubmed.ncbi.nlm.nih.gov/19505366
https://pubmed.ncbi.nlm.nih.gov/19505366
Autor:
Dolores Santos Buelga, María del Mar Fernández de Gatta, María José García, Alfonso Domínguez-Gil, Amparo Sánchez Navarro
Publikováno v:
Clinical pharmacokinetics. 48(4)
Background: The use of vancomycin against Staphylococcus aureus is currently debated because of the increasing resistance developed by this pathogen. Nevertheless, antibacterial effectiveness is a limited resource that must be protected and restored.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9589e477c79a531f18cf8876c6cef831
https://pubmed.ncbi.nlm.nih.gov/19492872
https://pubmed.ncbi.nlm.nih.gov/19492872